Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD

Chinese Medical Journal

Volumn 118, Issue 8, 2005, Pages 678-686

  Ye, Lü ^a   Zhang, Hong Ying ^a   Wang, Hua ^a   Yang, Guang Hua ^a   Bu, Hong ^a   Zhang, Li ^a   Wang, Shou Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cell cycle; Cyclin dependent kinase; Rhabdomyosarcoma; Transforming growth factor 1

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; MESSENGER RNA; PROTEIN; PROTEIN P15; PROTEIN P21; PROTEIN P27; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LASER MICROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TUMOR CELL LINE; WESTERN BLOTTING;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; GENES, MYC; HUMANS; RHABDOMYOSARCOMA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 17844377079     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Massague J, Chen YG. Controlling TGF-β signaling. Genes Dev 2000; 14: 627-644.
2. Howe PH, Draetta G., Leof EB. Transforming growth factorβ1 inhibition of p34/CDC2 phosphorylation and histone H1 activity is associated with G1/S-phase growth arrest. Mol Cell Biol 1991; 11: 1185-1194.
3. Laiho M, DeCaprio JA, Ludlow JW, et al. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 1990; 62: 175-185.
4. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-β receptor. Nature 1994; 370: 341-347.
5. Rama S, Suresh Y, Rao AJ. TGF beta1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights. Mol Cell Endocrinol 2003; 206: 123-136.
6. Hsu S, Borke JL, Lewis JB, et al. Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. Cell Prolif 2002; 35: 183-192.
7. 34 (+) progenitors. Blood 2002; 99: 499-506.
8. Park C, Kim WS, Choi Y, et al. Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis. Lung Cancer 2002; 38: 143-147.
9. Donovan JC, Rothenstein JM, Slingerland JM. Nonmalignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest. J Biol Chem 2002; 277: 41686-41692.
10. Hannon GJ, Beach D. P15ink4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-261.
11. Sandhu C, Garbe J, Bhattacharya N, et al. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol 1997; 17: 2458-2467.
12. Datto MB, Li Y, Panus JF, et al.. Tranforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995; 92: 5545-5549.
13. Li C, Suardet L, Little JB. Potential role of WAF/Cip/p21 as a mediator of TGF-βcytoinhibitory effect. J Biol Chem 1995; 270: 4971-4974.
14. Polyak K, Kato J, Solomon MJ, et al. p27Kip1, a cyclin-CDK inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22.
15. Polyak K, Lee MH, Ergumnet-Bromage H, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
16. Florenes VA, Bhattacharya N, Bani R, et al. TGF-β mediated G1 arrest in a human melanoma cell line lacking p15: evidence for cooperation between p21/CIP1 and p27/KIP. Oncogene 1996; 91: 2447-2457.
17. Vidal A, Koff A. Cell cycle inhibitors: three families united by a common cause. Gene 2000; 247: 1-15.
18. Law BK, Chytil A, Dumont N, et al. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol 2002; 22: 8184-8198.
19. Geng Y, Weinberg RA. Transforming growth factor β affects expression of G1 cyclins and cyclin-dependent protein kinase. Proc Natl Acad Sci U S A 1993; 90: 10315-10319.
20. Ewen ME, Sluss HK, Whitehouse L, et al. TGF-β inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009-1020.
21. Ko T, Sheng HM, Reisman D, et al. Transforming growth factor-β1 inhibition cyclinD1 expression in intestinal epithelial cells. Oncogene 1995; 10: 177-184.
22. Hu X, Zhang X, Zhong Q, et al. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells. Oncogene 2001; 20: 6840-6850.
23. Stacy WB, Massague J. Different sensitivity of the transforming growth factor-β cell cycle arrest pathway to c-myc and MDM-2. J Biol Chem 2000; 275: 32066-32070.
24. Yagi K, Furuhashi M, Aoki H, et al. c-myc is a downstream target of the Smad pathway. J Biol Chem 2002; 277: 854-861.
25. Kim AH, Lebman DA, Dietz CM, et al. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. Int J Oncol 2003; 23: 1593-1599.
26. Xie L, Law BK, Aakre ME, et al. Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res 2003; 5: R187-198.
27. Berger DH, Feng XH, Yao J, et al. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation. Surgery 2002; 132: 310-316.
28. Wang H, Yang GH, Bu H. The expression of TGF-β1 and TGF-β receptors in human rhambdomyosarcoma. J Clin Exp Pathol (Chin) 2002; 18: 61-64.
29. Reynisdottir J, Polyak K, Iavarone A, et al. Kip/Cip and Ink4 Cdk inhibitors cooperate to reduced cell cycle arrest in response to TGF-β. Genes Dev 1995; 9: 1831-1845.
30. Reynisdottir J, Massague J. The subcellular locations of p15INK4B and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 1997; 11: 492-503.
31. Dang CV. C-myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999; 19: 1-11.
32. Grandori C, Eisenman R. Myc target genes. Trends Biochem Sci 1997; 22: 177-181.
33. Henriksson M, Luscher B. Proteins of the myc network: essential regulatiors of cell growth and differentiation. Adv Cancer 1996; 68: 109-182.
34. Iavarone A, Massague J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor P15. Nature 1997; 387: 417-422.
35. Malliri A, Yeudall WA, Nikolic M, et al. Sensitivity to transforming growth factor beta-1 induced growth arrest is common in human squamous cell carcinoma cell lines: c-myc downregulation and P21 Waf1 induction are important early events. Cell Growth Differ 1996; 7: 1291-1304.
36. Pietenpol JA, Stein RW, Moran E, et al. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domains. Cell 1990; 61: 777-785.
37. Warner BJ, Blain SW, Seoane J, et al. Myc downregulation by transforming growth factor beta required for activation of the p15 (Ink4b) G(1) arrest pathway. Mol Cell Biol 1999; 19: 5913-5922.
38. Rao P, Kadesch T. The intracellular form of notch blocks transforming growth factor beta-mediated growth arrest in Mv1Lu epithelial cells. Mol Cell Biol 2003; 23: 6694-6701.
39. Seoane J, Pouponnot C, Staller P, et al. TGF beta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 2001; 3: 400-408.
40. Staller P, Peukert K, Kiermaier A, et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 2001; 3: 392-399.
41. Classen GF, Hann SR. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc Natl Acad Sci U S A 2000; 97: 9498-9503.
42. Wimmel A, Wiedenmann B, Rosewicz S. Autocrine growth inhibition by transforming growth factor beta-1 (TGF beta-1) in human neuroendocrine tumour cells. Gut 2003; 52: 1308-1316.
43. Hyang RJ, Uhee J, Chung HS, et al. Aberrant signaling of TGF-β1 by the mutant smad4 in gastric cancer cells. Cancer Lett 2003; 196: 197-206.
44. Dulic V, Kaufmann Wk, Wilson SJ, et al. P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994; 76: 1013-1023.
45. El-Deiry WS, Harper JW, O'Connor PM, et al. P21/WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1993; 54: 1169-1174.
46. Hu PP, Shen X, Huang D, et al. The MEK pathway is required for stimulation of p21/WAF1/CIP1 by transforming growth factor-β. J Biol Chem 1999; 274: 35381-35387.